Integrated Filing — IndAS

General information about company
Scrip Code	532612
NSE Symbol	INDOCO
MSEI Symbol	NOTLISTED
ISIN	INE873D01024
Name of company	INDOCO REMEDIES LIMITED
Type of company	Main Board
Class of security	Equity
Date of start of financial year	01-Apr-2024
Date of end of financial year	31-Mar-2025
Date of board meeting when results were approved	22-May-2025
Date on which prior intimation of the meeting for considering financial results was informed to the exchange	14-May-2025
Description of presentation currency	INR (in Actuals)
Reporting Type	Quarterly
Reporting Quarter	Fourth quarter
Nature of report standalone or consolidated	Consolidated
Whether results are audited or unaudited for the quarter ended	Audited
Whether results are audited or unaudited for the Year to date for current period ended/year ended	Audited
Segment Reporting	Single segment
Description of single segment	Pharmaceuticals
Start date and time of board meeting	22-May-2025   12:56:00
End date and time of board meeting	22-May-2025   14:25:00
Whether cash flow statement is applicable on company	Yes
Type of cash flow statement	Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification	Declaration of unmodified opinion

Financial Results Ind-AS
Particulars		3 months/ 6 months ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
A	Date of start of reporting period	01-Jan-2025	01-Apr-2024
B	Date of end of reporting period	31-Mar-2025	31-Mar-2025
C	Whether results are audited or unaudited	Audited	Audited
D	Nature of report standalone or consolidated	Consolidated	Consolidated
Part I	Blue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column.
1	Income
	Revenue from operations	3902100000	16649200000
	Other income	20200000	54500000
	Total income	3922300000	16703700000
2	Expenses
(a)	Cost of materials consumed	858600000	3962700000
(b)	Purchases of stock-in-trade	306200000	1409300000
(c)	Changes in inventories of finished goods, work-in-progress and stock-in-trade	-105100000	-390200000
(d)	Employee benefit expense	1063600000	3940500000
(e)	Finance costs	179800000	662300000
(f)	Depreciation, depletion and amortisation expense	287800000	1138400000
(f)	Other Expenses
1	Research & Development Expenses	173900000	760100000
2	Other Expenses	1612700000	5974200000
	Total other expenses	1786600000	6734300000
	Total expenses	4377500000	17457300000
3	Total profit before exceptional items and tax	-455200000	-753600000
4	Exceptional items	0	9900000
5	Total profit before tax	-455200000	-743700000
6	Tax expense
7	Current tax	-27000000	4700000
8	Deferred tax	-14800000	31100000
9	Total tax expenses	-41800000	35800000
10	Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement	0	0
11	Net Profit Loss for the period from continuing operations	-413400000	-779500000
12	Profit (loss) from discontinued operations before tax	0	0
13	Tax expense of discontinued operations	0	0
14	Net profit (loss) from discontinued operation after tax	0	0
15	Share of profit (loss) of associates and joint ventures accounted for using equity method	0	0
16	Total profit (loss) for period	-413400000	-779500000
17	Other comprehensive income net of taxes	-29300000	-41300000
18	Total Comprehensive Income for the period	-442700000	-820800000
19	Total profit or loss, attributable to
	Profit or loss, attributable to owners of parent	-403900000	-737400000
	Total profit or loss, attributable to non-controlling interests	-9500000	-9500000
20	Total Comprehensive income for the period attributable to
	Comprehensive income for the period attributable to owners of parent	-433200000	-778700000
	Total comprehensive income for the period attributable to owners of parent non-controlling interests	-9500000	-42100000
21	Details of equity share capital
	Paid-up equity share capital	184500000	184500000
	Face value of equity share capital	2	2
27	Details of debt securities
22	Reserves excluding revaluation reserve		10035500000
23	Earnings per share
i	Earnings per equity share for continuing operations
	Basic earnings (loss) per share from continuing operations	-4.48	8.46
	Diluted earnings (loss) per share from continuing operations	-4.48	8.45
ii	Earnings per equity share for discontinued operations
	Basic earnings (loss) per share from discontinued operations	0	0
	Diluted earnings (loss) per share from discontinued operations	0	0
ii	Earnings per equity share
	Basic earnings (loss) per share from continuing and discontinued operations	-4.48	8.46
	Diluted earnings (loss) per share from continuing and discontinued operations	-4.48	8.45
24	Debt equity ratio
25	Debt service coverage ratio
26	Interest service coverage ratio
27	Disclosure of notes on financial results

Remarks
Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio

Statement of Asset and Liabilities
Particulars		Year ended (dd-mm-yyyy)
Date of start of reporting period		01-Apr-2024
Date of end of reporting period		31-Mar-2025
Whether results are audited or unaudited		Audited
Nature of report standalone or consolidated		Consolidated
	Assets
1	Non-current assets
	Property, plant and equipment	8490600000
	Capital work-in-progress	2761200000
	Investment property
	Goodwill	215200000
	Other intangible assets	1263000000
	Intangible assets under development	444200000
	Biological assets other than bearer plants
	Investments accounted for using equity method
	Non-current financial assets
	Non-current investments	14600000
	Trade receivables, non-current
	Loans, non-current	36100000
	Other non-current financial assets	62400000
	Total non-current financial assets	113100000
	Deferred tax assets (net)
	Other non-current assets	998400000
	Total non-current assets	14285700000
2	Current assets
	Inventories	4193500000
	Current financial asset
	Current investments	0
	Trade receivables, current	3524100000
	Cash and cash equivalents	121000000
	Bank balance other than cash and cash equivalents	49700000
	Loans, current	33100000
	Other current financial assets	33400000
	Total current financial assets	3761300000
	Current tax assets (net)	184100000
	Other current assets	1874500000
	Total current assets	10013400000
3	Non-current assets classified as held for sale
4	Regulatory deferral account debit balances and related deferred tax Assets
	Total assets	24299100000
	Equity and liabilities
1	Equity
	Equity attributable to owners of parent
	Equity share capital	184500000
	Other equity	10035500000
	Total equity attributable to owners of parent	10220000000
	Non controlling interest	-36200000
	Total equity	10183800000
2	Liabilities
	Non-current liabilities
	Non-current financial liabilities
	Borrowings, non-current	5425600000
	Trade payables, non-current
	(A) Total outstanding dues of micro enterprises and small enterprises
	(B) Total outstanding dues of creditors other than micro enterprises and small enterprises
	Total Trade payable
	Other non-current financial liabilities	43900000
	Total non-current financial liabilities	5469500000
	Provisions, non-current	358200000
	Deferred tax liabilities (net)	133600000
	Deferred government grants, Non-current
	Other non-current liabilities	74100000
	Total non-current liabilities	6035400000
	Current liabilities
	Current financial liabilities
	Borrowings, current	4510000000
	Trade payables, current
	(A) Total outstanding dues of micro enterprises and small enterprises	559000000
	(B) Total outstanding dues of creditors other than micro enterprises and small enterprises	1522300000
	Total Trade payable	2081300000
	Other current financial liabilities	805500000
	Total current financial liabilities	7396800000
	Other current liabilities	231600000
	Provisions, current	451500000
	Current tax liabilities (Net)
	Deferred government grants, Current
	Total current liabilities	8079900000
3	Liabilities directly associated with assets in disposal group classified as held for sale
4	Regulatory deferral account credit balances and related deferred tax liability
	Total liabilities	14115300000
	Total equity and liabilites	24299100000
	Disclosure of notes on assets and liabilities

Format for Reporting Segmenet wise Revenue, Results and Capital Employed along with the company results
Particulars		3 months/ 6 month ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period		01-Jan-2025	01-Apr-2024
Date of end of reporting period		31-Mar-2025	31-Mar-2025
Whether accounts are audited or unaudited		Audited	Audited
Nature of report standalone or consolidated		Consolidated	Consolidated
1	Segment Revenue (Income)
	(net sale/income from each segment should be disclosed)
	Total Segment Revenue
	Less: Inter segment revenue
	Revenue from operations
2	Segment Result
	Profit (+) / Loss (-) before tax and interest from each segment
	Total Profit before tax
	i. Finance cost
	ii. Other Unallocable Expenditure net off Unallocable income
	Profit before tax
3	(Segment Asset - Segment Liabilities)
	Segment Asset
	Total Segment Asset
	Un-allocable Assets	null	null
	Net Segment Asset	null	null
4	Segment Liabilities
	Segment Liabilities
	Total Segment Liabilities
	Un-allocable Liabilities	null	null
	Net Segment Liabilities	null	null
	Disclosure of notes on segments

Other Comprehensive Income
Particulars		3 months/ 6 months ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
A	Date of start of reporting period	01-Jan-2025	01-Apr-2024
B	Date of end of reporting period	31-Mar-2025	31-Mar-2025
C	Whether results are audited or unaudited	Audited	Audited
D	Nature of report standalone or consolidated	Consolidated	Consolidated
	Other comprehensive income [Abstract]
1	Amount of items that will not be reclassified to profit and loss
1	Items that will not be reclassified to profit & loss	-51400000	-60400000
	Total Amount of items that will not be reclassified to profit and loss	-51400000	-60400000
2	Income tax relating to items that will not be reclassified to profit or loss	-12900000	-15200000
3	Amount of items that will be reclassified to profit and loss
1	Items that may be reclassified to profit & loss	10300000	3300000
	Total Amount of items that will be reclassified to profit and loss	10300000	3300000
4	Income tax relating to items that will be reclassified to profit or loss	1100000	-600000
5	Total Other comprehensive income	-29300000	-41300000

Cash flow statement, indirect
Particulars				Year ended (dd-mm-yyyy)
A	Date of start of reporting period			2024-04-01
B	Date of end of reporting period			2025-03-31
C	Whether results are audited or unaudited			Audited
D	Nature of report standalone or consolidated			Consolidated
Part I	Blue color marked fields are non-mandatory.
	Statement of cash flows
	Cash flows from used in operating activities
	Profit before tax			-743700000
	Adjustments for reconcile profit (loss)
	Adjustments for finance costs			662300000
	Adjustments for decrease (increase) in inventories			-662900000
	Adjustments for decrease (increase) in trade receivables, current			506500000
	Adjustments for decrease (increase) in trade receivables, non-current			0
	Adjustments for decrease (increase) in other current assets			-338300000
	Adjustments for decrease (increase) in other non-current assets			-4800000
	Adjustments for other financial assets, non-current			-200000
	Adjustments for other financial assets, current			18000000
	Adjustments for other bank balances			0
	Adjustments for increase (decrease) in trade payables, current			545700000
	Adjustments for increase (decrease) in trade payables, non-current			0
	Adjustments for increase (decrease) in other current liabilities			86800000
	Adjustments for increase (decrease) in other non-current liabilities			0
	Adjustments for depreciation and amortisation expense			1138400000
	Adjustments for impairment loss reversal of impairment loss recognised in profit or loss			0
	Adjustments for provisions, current			-32200000
	Adjustments for provisions, non-current			-39000000
	Adjustments for other financial liabilities, current			-87000000
	Adjustments for other financial liabilities, non-current			35200000
	Adjustments for unrealised foreign exchange losses gains			15500000
	Adjustments for dividend income			0
	Adjustments for interest income			8400000
	Adjustments for share-based payments			22000000
	Adjustments for fair value losses (gains)			0
	Adjustments for undistributed profits of associates			0
	Other adjustments for which cash effects are investing or financing cash flow			0
	Other adjustments to reconcile profit (loss)			8200000
	Other adjustments for non-cash items			-1600000
	Share of profit and loss from partnership firm or association of persons or limited liability partnerships			0
	Total adjustments for reconcile profit (loss)			1864200000
	Net cash flows from (used in) operations			1120500000
	Dividends received			0
	Interest paid			0
	Interest received			0
	Income taxes paid (refund)			171200000
	Other inflows (outflows) of cash			0
	Net cash flows from (used in) operating activities			949300000
	Cash flows from used in investing activities
	Cash flows from losing control of subsidiaries or other businesses			0
	Cash flows used in obtaining control of subsidiaries or other businesses			0
	Other cash receipts from sales of equity or debt instruments of other entities			79000000
	Other cash payments to acquire equity or debt instruments of other entities			0
	Other cash receipts from sales of interests in joint ventures			0
	Other cash payments to acquire interests in joint ventures			0
	Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships			0
	Cash payment for investment in partnership firm or association of persons or limited liability partnerships			0
	Proceeds from sales of property, plant and equipment			38000000
	Purchase of property, plant and equipment			3561500000
	Proceeds from sales of investment property			0
	Purchase of investment property			0
	Proceeds from sales of intangible assets			0
	Purchase of intangible assets			0
	Proceeds from sales of intangible assets under development			0
	Purchase of intangible assets under development			0
	Proceeds from sales of goodwill			0
	Purchase of goodwill			0
	Proceeds from biological assets other than bearer plants			0
	Purchase of biological assets other than bearer plants			0
	Proceeds from government grants			0
	Proceeds from sales of other long-term assets			0
	Purchase of other long-term assets			0
	Cash advances and loans made to other parties			0
	Cash receipts from repayment of advances and loans made to other parties			0
	Cash payments for future contracts, forward contracts, option contracts and swap contracts			0
	Cash receipts from future contracts, forward contracts, option contracts and swap contracts			0
	Dividends received			0
	Interest received			8400000
	Income taxes paid (refund)			0
	Other inflows (outflows) of cash			45000000
	Net cash flows from (used in) investing activities	-3391100000
	Cash flows from used in financing activities
	Proceeds from changes in ownership interests in subsidiaries			0
	Payments from changes in ownership interests in subsidiaries			0
	Proceeds from issuing shares			0
	Proceeds from issuing other equity instruments			15900000
	Payments to acquire or redeem entity's shares			0
	Payments of other equity instruments			0
	Proceeds from exercise of stock options			0
	Proceeds from issuing debentures notes bonds etc			0
	Proceeds from borrowings			2642900000
	Repayments of borrowings			-585800000
	Payments of lease liabilities			52300000
	Dividends paid			139000000
	Interest paid			639100000
	Income taxes paid (refund)			0
	Other inflows (outflows) of cash			0
	Net cash flows from (used in) financing activities			2414200000
	Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes			-27600000
	Effect of exchange rate changes on cash and cash equivalents
	Effect of exchange rate changes on cash and cash equivalents			0
	Net increase (decrease) in cash and cash equivalents			-27600000
	Cash and cash equivalents cash flow statement at beginning of period			148600000
	Cash and cash equivalents cash flow statement at end of period			121000000